Relationship between disease severity and post-treatment, long-term efficacy of 300IR 5-grass pollen sublingual tablets

被引：0
|
作者：
Didier, A. [1 ]
Malling, H. [2 ]
Worm, M. [3 ]
Amistani, Y. [4 ]
Le Gall, M. [4 ]
Zeldin, R. [4 ]
机构：
[1] Rangueil Larrey Hosp, Dept Resp Dis, Toulouse, France
[2] Natl Univ Hosp, Copenhagen, Denmark
[3] Univ Med Berlin, Allergie Ctr Charite, Klin Dermatol Venerol & Allergol, Berlin, Germany
[4] Stallergenes, Antony, France
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
311
引用
收藏
页码：135 / 135
页数：1
相关论文
共 44 条
  • [21] DISEASE-MODIFYING EFFECT OF 300IR 5-GRASS POLLEN SUBLINGUAL TABLETS IN THE TREATMENT OF GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS IN ADULTS: ASSESSMENT OVER AN ADDITIONAL IMMUNOTHERAPY-FREE POLLEN SEASON
    Didier, A.
    Melac, M.
    Soulie, S.
    Furrer, M. P.
    Zeldin, R. K.
    RESPIROLOGY, 2012, 17 : 53 - 53
  • [22] SAFETY OF 300IR 5-GRASS POLLEN SUBLINGUAL TABLET FOR THE TREATMENT OF GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS IN ADULTS AND PEDIATRIC SUBJECTS WITH INTERMITTENT ASTHMA
    Parkes, Alicia
    Cognet-Sice, Josiane
    Abiteboul, Kathy
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 20 - 20
  • [23] Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE
    Cox, Linda S.
    Casale, Thomas B.
    Nayak, Anjuli S.
    Bernstein, David I.
    Creticos, Peter S.
    Ambroisine, Laurence
    Melac, Michel
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 130 (06) : 1327 - +
  • [24] POST-MARKETING SAFETY EXPERIENCE WITH 300IR 5-GRASS POLLEN TABLET FOR ALLERGIC RHINOCONJUNCTIVITIS
    Abiteboul, K.
    Golden, D.
    Brauer, K.
    Bons, B.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S39 - S40
  • [25] 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis
    Serrano, Elie
    Wahn, Hans Ulrich
    Didier, Alain
    Bachert, Claus
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2014, 28 (06) : 471 - 476
  • [26] Long-term Safety Of A 300IR Sublingual Tablet Of 5-grass-pollen Allergen Extract In Adults With Grass-pollen-induced Allergic Rhinoconjunctivitis
    Didier, A.
    Worm, M.
    Horak, F.
    Malling, H.
    Montagut, A.
    Zeldin, R. K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB248 - AB248
  • [27] Efficacy of 300IR 5-Grass Pollen Sublingual Tablet In Poly-sensitized Patients With Allergic Rhinoconjunctivitis-results of a US Study
    Zeldin, R. K.
    Paolozzi, L.
    Ambroisine, L.
    ALLERGY AND ASTHMA PROCEEDINGS, 2014, 35 (03) : 266 - 266
  • [28] Efficacy of 300ir 5-grass pollen sublingual tablet: Improvement in subjects with grass pollen-induced allergic rhinoconjunctivitis based on well days and severe days evaluation
    Brehmer, D.
    Karagiannis, E.
    Montagut, A.
    Abiteboul, K.
    ALLERGY, 2017, 72 : 277 - 278
  • [29] Sustained and post-treatment efficacy of a 5-grass pollen allergen extract sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
    Zeldin, R. K.
    Melac, M.
    Amistani, Y.
    Didier, A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (03) : 298 - 298
  • [30] Long-term clinical efficacy of a 5-grass pollen sublingual immunotherapy tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Montagut, A.
    Galvain, S.
    Rodriguez, P.
    Malling, H.
    ALLERGY, 2011, 66 : 654 - 654
12345